Assessment of Plant-based Program Using Shared Medical Appointment

An Interprofessional-led Model of Care to Prevent and Treat Chronic Diseases Using a Whole Food, Plant-based Nutrition Program in a Primary Care Setting

Evaluation of the impact of a whole food, plant-based (WFPB) program using shared medical appointments (SMAs) on reducing cardiovascular risk factors and weight loss in overweight/obese adults with at least one chronic disease

Study Overview

Status

Completed

Detailed Description

The study will use a single-arm with participants enrolled in three groups of 15 each (n=45) into the Green Wellness Program: Plants-2-Plate, an established program focusing on WFPB predominant eating pattern in an academic primary care setting. The program will offer 14 SMAs in a period of 6 months. Participants will attend the SMA weekly for 3 months, followed by a monthly SMA for the last 3 months of the intervention period. In the first session, participants will receive information about the program, and establish a health goal to be met at the end of the program. Each weekly SMA will have a nutrition education lesson, and feedback from the FNP, RN and RD after a brief assessment on health, medication adjustment, food choices, and shared ideas and experiences among the participants. At the end of the session, participants will set a small health goal to be followed during the week with assistance from the inter-professional team. The WFPB dietary approach includes vegetables, fruits, legumes, whole grains, seeds, nuts in small portion, elimination of all or most of animal foods, and reduction of processed food. Participants will eat ad libitum. In addition, they will receive support to manage stress, improve quality of sleep, and increase physical activity during the SMA.

Study Type

Interventional

Enrollment (Actual)

47

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • San Antonio, Texas, United States, 78229
        • UT Health San Antonio, School of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Men and women >18 years
  • Either overweight (BMI > 25kgm-2) or obese (BMI >30 kgm-2)
  • Diagnosis of one or more chronic diseases
  • Own a smartphone or tablet that has reliable interned/data access
  • Agrees to comply with all study requirements
  • Can speak and understand English

Exclusion Criteria:

  • Diagnosis of cancer
  • Previous participant in Green Wellness program: Plants-2-Plate
  • Pregnant or planning to become pregnant
  • Breastfeeding
  • Concurrent weight loss program
  • Plans to leave the city or USA for over 2 weeks within 6 months of enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Green Wellness Program: Plants-2-Plate
The Green Wellness Program:Plants-2-Plate is an established program focusing on whole food plant-based predominant eating pattern in academic primary care setting.The dietary approach includes vegetables, fruits, legumes, whole grains, seeds, nuts in small portion, elimination of all or most of animal foods, and reduction of processed foods. Participants will eat ad libitum. In addition, they will receive support to manage stress, improve quality of sleep, and increase physical activity during the SMA.
A 6-month, intensive interprofessional program focused on a WFPB predominant eating pattern
Other Names:
  • Whole food, plant-based program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Cholesterol from blood chemistry panel
Time Frame: Baseline to 6 months
Change in Total Cholesterol from program beginning to end
Baseline to 6 months
Low Density Lipoprotein (LDL) from blood chemistry panel
Time Frame: Baseline to 6 months
Change in LDL-cholesterol from program beginning to end
Baseline to 6 months
HDL-Cholesterol from blood chemistry panel
Time Frame: Baseline to 6 months
Change in HDL-cholesterol from program beginning to end
Baseline to 6 months
Triglycerides from blood chemistry panel
Time Frame: Baseline to 6 months
Change in triglycerides from program beginning to end
Baseline to 6 months
Tumor necrosis factor-alfa (TNF-α) from blood inflammatory biomarker
Time Frame: Baseline to 6 months
Change in TNF-α from program beginning to end
Baseline to 6 months
Interleukin (IL)-18 measurement from blood test
Time Frame: Baseline to 6 months
Change in Interleukin (IL)-18 from program beginning to end
Baseline to 6 months
C-reactive protein (HsCRP) measurement from blood test
Time Frame: Baseline to 6 months
Change in HsCRP from program beginning to end
Baseline to 6 months
Soluble Intercellular Adhesion Molecule-1 (sICAM1) measurement from blood test
Time Frame: Baseline to 6 months
Change in sICAM1 from program beginning to end
Baseline to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to WFPB measurement
Time Frame: Baseline to 6 months
Pattern of adherence is tracked by a mobile health device by number of days of adherence to program
Baseline to 6 months
Physical activity measurement
Time Frame: Baseline to 6 months
Time spent daily on physical activity daily
Baseline to 6 months
Systolic Blood pressure measurement
Time Frame: Baseline to 6 months
Change in Systolic blood pressure from program beginning to end
Baseline to 6 months
Diastolic Blood pressure measurement
Time Frame: Baseline to 6 months
Change in Diastolic blood pressure from program beginning to end
Baseline to 6 months
Waist circumference measurement
Time Frame: Baseline to 6 months
Change in waist circumference from program beginning to end
Baseline to 6 months
Weight measurement
Time Frame: Baseline to 6 months
Change in weight from program beginning to end
Baseline to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Christiane L Meireles, PhD, University of Texas Health Science Center San Antonio

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2023

Primary Completion (Actual)

February 7, 2024

Study Completion (Actual)

February 7, 2024

Study Registration Dates

First Submitted

May 22, 2023

First Submitted That Met QC Criteria

June 1, 2023

First Posted (Actual)

June 5, 2023

Study Record Updates

Last Update Posted (Actual)

March 21, 2024

Last Update Submitted That Met QC Criteria

March 20, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • HSC20220903H

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data (IPD) collected during the trial that underlie the results reported will be shared after de-identification.

IPD Sharing Time Frame

Data will be available at the time of publication with no end date.

IPD Sharing Access Criteria

Not yet determined.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Disease

Clinical Trials on Green Wellness Program: Plants-2-Plate

Subscribe